|
J Biol Chem, Vol. 275, Issue 11, 8226-8232, March 17, 2000
Cleavage Preferences of the Apoptotic Endonuclease DFF40
(Caspase-activated DNase or Nuclease) on Naked DNA and Chromatin
Substrates*
Piotr
Widlak §,
Peng
Li¶,
Xiaodong
Wang **, and
William T.
Garrard 
From the Departments of Molecular Biology and
Biochemistry and the ** Howard Hughes Medical Institute,
University of Texas Southwestern Medical Center,
Dallas, Texas 75235
 |
ABSTRACT |
Here we report the co-factor requirements for DNA
fragmentation factor (DFF) endonuclease and characterize its cleavage
sites on naked DNA and chromatin substrates. The endonuclease exhibits a pH optimum of 7.5, requires Mg2+, not
Ca2+, and is inhibited by Zn2+. The enzyme
generates blunt ends or ends with 1-base 5'-overhangs possessing
5'-phosphate and 3'-hydroxyl groups and is specific for double- and not
single-stranded DNA or RNA. DFF endonuclease has a moderately greater
sequence preference than micrococcal nuclease or DNase I, and the sites
attacked possess a dyad axis of symmetry with respect to purine and
pyrimidine content. Using HeLa cell nuclei or chromatin reconstituted
on a 5 S rRNA gene tandem array, we prove that the enzyme attacks
chromatin in the internucleosomal linker, generating oligonucleosomal
DNA ladders sharper than those created by micrococcal nuclease.
Histone H1, high mobility group-1, and topoisomerase II activate
DFF endonuclease activity on naked DNA substrates but much less so on
chromatin substrates. We conclude that DFF is a useful reagent for
chromatin research.
 |
INTRODUCTION |
Apoptosis, or programmed cell death, plays an important role in
the development of an organism and in the maintenance of tissue homeostasis (reviewed in Refs. 1 and 2). Hallmarks of the terminal
stages of apoptosis are nucleosomal DNA fragmentation (also termed here
"DNA laddering") and chromatin condensation (3-5). The
endonuclease primarily responsible for mediating DNA laddering is
activated by caspase-3 treatment of
DFF.1 In its inactive form,
DFF is a heterodimer composed of a 45-kDa chaperone and inhibitor
subunit (DFF45/ICAD) and a 40-kDa latent endonuclease subunit
(DFF40/CAD/CPAN) (6-10). This protein complex resides in the cell
nucleus (7, 11). Caspase-3 cleavage of DFF specifically cuts only
DFF45, which results in the dissociation of cleaved DFF45 from DFF40
(6-10). Interestingly, the released endonuclease forms homo-oligomers
that are the enzymatically active form of DFF40 (12). In addition, its
activity on naked DNA substrates can be further activated by specific
chromosomal proteins, such as histone H1 or HMG-1/2 (7, 12, 13), and
topoisomerase II (this report). Furthermore, chromatin condensation can
be initiated in isolated nuclei by the addition of recombinant
activated DFF40, purified free of caspase-3 and DFF45 breakdown
products (7).
It should be noted that the physiological significance of DFF in
triggering DNA laddering and chromatin condensation during apoptosis
has been unequivocally proven. A homozygous deletion of the single copy
gene encoding DFF45 has been created in the mouse germ line (14).
Significantly, thymocytes and splenocytes from these knockout mice
exhibit greatly reduced DNA laddering or chromatin condensation when
exposed to apoptotic stimuli, both in vivo and in
vitro, proving that DFF is a principal player for the induction of
these events (14, 15). Furthermore, such mice still express DFF40,
indicating that the chaperone function of DFF45 is required in
vivo for creating a potentially functional DFF40
endonuclease.2 Other gene
products also appear to participate in the DFF pathway. Two proteins
encoded by genes called cell death-inducing DFF45-like effectors, or
CIDEs, which exhibit homology to the N-terminal domain of DFF45, can
activate apoptosis in a DFF45-inhibitable fashion, but their precise
mechanism of action remains to be elucidated (16). In addition, an
isoform of DFF45, termed DFF35 (also termed ICAD-S (9)), is incapable
of acting as a chaperone and acts as an inhibitor of the latent
endonuclease (17, 18). In conclusion, it is well established
experimentally that DFF plays a major and regulated role in apoptotic
DNA fragmentation and chromatin condensation, although other pathways
have also been identified (19, 20).
Nucleases have proven to be valuable reagents for the analysis of
chromatin structure (21). Because apoptotic nucleases are known to
efficiently create DNA ladders composed of total genomic sequences, if
DFF40 is the major player in such laddering, then its sequence
specificity for DNA cleavage would appear to be broad enough to be a
useful additional tool for chromatin research. Here we report the
cleavage site preferences for DFF40 on naked DNA and chromatin
substrates and demonstrate that DFF40 is indeed a useful reagent for
generating sharp internucleosomal DNA cleavage.
 |
EXPERIMENTAL PROCEDURES |
Nuclease Chromatin Substrates--
HeLa cell nuclei were
purified as described elsewhere (6). Nuclei were successively washed at
4 °C in 3 mM MgCl2, 10 mM KCl, 1 mM dithiothreitol, 20 mM Tris, pH 7.6, 0.2 M sucrose (buffer A) plus 1% Triton X-100 and then in
buffer A alone, suspended at 1 µg/µl as DNA in buffer A plus 20%,
glycerol and aliquots were stored at 80 °C. Chromatin was
reconstituted on a tandem 18-mer array of the Lytechinus
variegatus 5 S rRNA gene (22), recloned into the vector pGEM3A to
yield the recombinant plasmid pGH 207-18 (gift of Dr. Joe Gatewood, Los
Alamos National Laboratory). The 18-mer was excised from pGH 207-18 by
digestion with HhaI and purified from agarose gels after
electrophoresis. Chromatin was reconstituted using a salt step dialysis
procedure (23, 24). Core histones were purified from HeLa nuclei.
Briefly, nuclei were incubated with MNase (Worthington) and washed with buffer containing 1 mM EGTA, and chromatin was eluted with
2 mM EDTA. Chromatin was equilibrated with 0.4 M NaCl and loaded onto a hydroxyapatite column. After
washing the column extensively with 0.4 M NaCl, histone H1
was eluted with 0.6 M NaCl, and core histones were
subsequently eluted with 2 M NaCl (25); no other protein
bands were visible on overloaded SDS-polyacrylamide gels. Core histones
were mixed with DNA at a histone:DNA weight ratio of 1.4 in 2.5 M NaCl, 20 mM Tris, 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, pH 7.6. The mixture was
incubated for 15 min at 37 °C, added to a dialysis tube (SpectraPor;
Mr cut-off of 6000-8000) and dialyzed at
4 °C as follows: 2 h with 1 M NaCl, 3 h with
0.55 M NaCl, 4 h with 0.25 M NaCl, and
finally 12 h with buffer without NaCl. If histone H1 was also to
be assembled into chromatin, histone H1 purified from HeLa cell nuclei
as described above was added at the 0.55 M NaCl step at a
concentration of 0.28 µg/µg of DNA. Chromatin was concentrated
using Millipore Ultrafree-MC spin filters to about 0.25 µg of
DNA/µl and stored at 80 °C after glycerol was added to a final
concentration of 10%.
Assay for Endonuclease Activity--
Recombinant caspase-3 was
prepared as described (12). DFF was either purified from HeLa cells or
from an Escherichia coli expression system as reported
previously (6, 12). Similar results were obtained with either source of
the protein. However, the recombinant protein had a significantly lower
specific activity, possibly due to a lack of the appropriate
post-translational modifications. One µg of naked DNA, nuclei, or
chromatin (as DNA) was incubated at 37 °C with 1 µl of caspase-3
(0.2 µg) and 1 µl of DFF (1 unit) in buffer consisting of 10 mM KCl, 3 mM MgCl2, 0.5 mM dithiothreitol, 10 mM Hepes, pH 7.5 (final
volume 15 µl) for varying times, in the absence or presence of
supplemented proteins as indicated in the legends to Figs. 3, 4, and 6.
When comparisons were made between DFF and MNase, unless otherwise
indicated, 3 mM CaCl2 was added to the above
buffer for the MNase reactions. As controls, we routinely preincubated
caspase-3 with 10 µM Ac-DEAD-CHO (a tetrapeptide aldehyde
inhibitor of caspase-3) to demonstrate caspase-3 dependence on DFF
activation or similarly postincubated with the inhibitor to block any
further action of the protease before the addition of activated DFF to
any of the above substrates. Although we have found that digestion of
naked DNA by DFF was markedly more active under conditions of higher
monovalent cations (e.g. 50-100 mM), this is
not true for digestion of chromatin substrates; thus, to reduce
potential protein exchange and redistribution during digestion of
chromatin, we chose to employ buffers containing 10-25 mM
monovalent cations. Aliquots of the endonuclease reaction were mixed
with 1/2 volume of stop solution (0.6% SDS, 50 mM
EDTA, and 6 mg/ml proteinase K) and incubated for 1 h at 50 °C.
Gel loading dye buffer was added, and samples were then run on 1.5% SeaKem agarose gels using 1× TAE as the running buffer. After electrophoresis, DNA was stained with ethidium bromide, and gels were
scanned with a FluorImager (Molecular Dynamics Inc., Sunnyvale, CA).
Images were analyzed using ImageQuant software (Molecular Dynamics) and
have been represented as negatives. When radioactive DNA was used as
the substrate, gels were dried and imaged with a PhosphorImager
(Molecular Dynamics), and images were analyzed as above.
Analysis of Cleavage Sites--
For a relative comparison of DNA
cleavage site sequence preferences between different endonucleases,
pUC19 DNA was digested with EcoRI,
32P-5'-end-labeled with T4 polynucleotide kinase after
dephosphorylation, and then DNA circles were created in a T4 DNA
ligase-catalyzed reaction as described previously (26). Resulting DNA
circles (500 ng) were incubated with 0.25 units of MNase (Worthington) or with 0.0025 units of DNase I (Worthington) for 1, 2, 4, and 6 min,
or with 0.5 units of DFF with 0.2 µg of caspase-3 for 3, 9, 30, and
60 min at 37 °C. Reaction mixtures were 10 µl each and contained
MgCl2 and CaCl2 at 1.5 mM each. DNA
was purified, digested with AvaI, and separated on 5%
polyacrylamide sequencing gels. For detailed analyses of sequences at
cleavage sites, a 177-bp fragment of the HIV-1 5'-LTR DNA was excised
from plasmid pWLTR11 (26) with BglII and AvaI,
purified from an agarose gel after electrophoresis, and 5'-end-labeled
with T4 polynucleotide kinase. Labeled DNA was incubated with caspase-3
and DFF for 10 min at 37 °C, and then purified by phenol/chloroform
extraction and ethanol precipitation. To analyze cleavage sites on the
coding strand, DNA was digested with BsaI (releasing a 12-bp
fragment labeled at the BglII site and allowing direct
analysis from the AvaI site). To analyze cleavage sites on
the noncoding strand, DNA was digested with ScaI (releasing
a 20-bp fragment labeled at the AvaI site and allowing
direct analysis from the BglII site). Digestion products
were resolved on 6% polyacrylamide sequencing gels together with the
appropriate Sanger sequencing reactions (DNA was sequenced with the
Amersham T7 Sequenase version 2.0 sequencing kit according to the
vendor's protocol).
Analysis of DNA Ends--
Reconstituted chromatin was incubated
with caspase-3 and DFF, and then DNA was purified. Mononucleosomal DNA
was isolated after electrophoresis on a low melting agarose gel,
5'-end-dephosphorylated with shrimp alkaline phosphatase (Roche
Molecular Biochemicals), and 32P-5'-end labeled with T4
polynucleotide kinase. Aliquots of labeled DNA were digested with
EcoRI or 3'-end modified with either T4 DNA polymerase
(U. S. Biochemical Corp.) or terminal deoxynucleotidyl transferase
(U. S. Biochemical Corp.) according to the vendor's protocols. DNA
samples were then resolved on 6% polyacrylamide sequencing gels.
 |
RESULTS |
Caspase-3-activated DFF Requires Mg2+, not
Ca2+, and is Inhibited by Zn2+--
A variety
of endonucleases have been implicated in apoptotic DNA laddering,
including non-metal ion-dependent (27-29),
Ca2+- and Mg2+-dependent (30-37),
Mg2+-dependent (38, 39), and either
Ca2+- or Mg2+-dependent
endonucleases (40, 41). To rigorously establish the divalent ion
requirements for DFF, we first dialyzed the protein against a buffer
containing EDTA. We found that caspase-3-activated DFF endonuclease had
a pH optimum of 7.5 and only required Mg2+ and not
Ca2+ as its divalent cation, even in the presence of EGTA,
thereby eliminating the possibility that traces of contaminating
Ca2+ in Mg2+-containing solutions may be
required for its activity (data not shown) (see Ref. 42). Under the
optimal reaction conditions, the enzyme does not digest either
single-stranded DNA or RNA (data not shown). Because Zn2+
has been reported to block apoptotic DNA laddering in certain systems
(43, 44), we also tested this ion and found it to be a strong inhibitor
of DFF endonuclease activity (data not shown).
Caspase-3-activated DFF Possesses Moderately Greater Sequence
Preferences Than MNase and DNase I--
DFF potentially may be a
useful reagent for chromatin structural analyses. We therefore
evaluated DFF's sequence preferences for naked DNA cleavage in
comparison with those of MNase and DNase I, which have both been well
characterized previously (45-48). Separation of the corresponding
cleavage products of 32P-5'-labeled pUC19 DNA on a
sequencing gel reveals that caspase-3-activated DFF endonuclease
possesses moderately more sequence selectivity than either MNase or
DNase I (Fig. 1). Nevertheless, DNA
products are eventually processed to fragments 20 bp after more
extensive digestion (data not shown), indicating a quite broad sequence specificity, consistent with the fact that DFF endonuclease is capable
of converting purified HeLa cell DNA quantitatively into very small DNA
fragments (see below).

View larger version (80K):
[in this window]
[in a new window]
|
Fig. 1.
Comparison of DNA cleavage patterns of MNase,
DNase I, and caspase-3-activated DFF on naked DNA. Circular,
site-specific-32P-labeled pUC19 DNA was incubated with
MNase, DNase I, or DFF plus caspase-3 as indicated under
"Experimental Procedures." DNA was purified, digested with
AvaI, and separated on a 5% polyacrylamide sequencing gel.
G, Maxim-Gilbert sequencing reaction for guanines.
M, 100-bp ladder (Life Technologies, Inc.).
|
|
Caspase-3-activated DFF Generates Blunt Ends or Ends with a 1-Base
5'-Overhang--
We determined the nucleotide sequences at various
cleavage sites by using 32P-end-labeled DNA restriction
fragments as substrates and resolution of the Watson or Crick strands
on sequencing gels. As shown in Fig. 2,
the endonuclease generates blunt ends or ends with 1-base 5'-overhangs.
We analyzed 57 cleavage sites at the nucleotide level within the HIV-1
LTR, the mouse immunoglobulin gene, and pUC19 DNA. While these
analyses revealed no simple consensus cleavage sequence, there clearly
was a preference with respect to purines and pyrimidines. The
frequencies of the 4 bases found on each side of these cleavage sites
were as follows: 5'-R (72%), R (74%), R (66%), Y (61%) R
(65%), Y (67%), Y (75%), Y (75%)-3'. It is significant that this
purine/pyrimidine preference exhibits a rotational (dyad) symmetry.
This observation, together with the double-stranded cleavage activity
of this enzyme, is consistent with our observation that only
homo-oligomeric forms of DFF40 are enzymatically active (12).

View larger version (66K):
[in this window]
[in a new window]
|
Fig. 2.
Analysis of caspase-3-activated DFF DNA
cleavage sites. A 177-bp fragment corresponding to
32P-end-labeled HIV-1 5'-LTR DNA was incubated with
caspase-3 and DFF. Fragments generated were cut with either
BsaI or ScaI to reveal the coding or noncoding
strand patterns after being resolved on a sequencing gel
(DFF lanes) in parallel with sequencing reaction
products as indicated. The arrowheads depict cleavage
products and the positions of DNA strand cleavage within the
sequence.
|
|
Oligonucleosomal Ladders Generated by Caspase-3-activated DFF Are
Sharper than Those Created by MNase--
To determine the utility of
DFF as a reagent for chromatin research, we compared its action with
that of MNase for generating oligonucleosomal DNA ladders. As shown in
Fig. 3, digestion of chromatin in
isolated HeLa cell nuclei was dependent on the presence of either
enzyme (compare lanes 1 and 2 with
lanes 4-7 and 9-12) and for DFF
required caspase-3 cleavage (compare lanes 14-16
with lanes 9-12). The average nucleosomal DNA
repeat length estimated after digestion by either enzyme was
approximately 180 bp, in reasonable agreement with previous reports
(21). Quantitation by PhosphorImager analysis revealed that 70% of the
total genomic DNA could be processed to mononucleosomes by DFF after
extensive digestion (Fig. 3A, lane 9).
This incompleteness was not due to DFF-resistant sequences in the human
genome, because high molecular weight naked HeLa cell DNA could be
quantitatively converted to very small DNA fragments upon digestion by
the enzyme (Fig. 3B, lanes 2-6). The
incomplete conversion to mononucleosomes may be due to a subfraction of
the genome being organized into DFF-resistant chromatin structures,
and/or to nuclear heterogeneity in DFF permeability; DFF forms very
large oligomeric complexes upon activation (12), and its nuclear access
may be partially limited. Consistent with this view is that the
addition of 1 mM GTP to reaction mixtures stimulated the
digestion kinetics about 2-fold on the nuclear substrate but had no
affect on naked DNA digestion kinetics (data not shown), presumably by
enhancing the nuclear import and/or retention of DFF by
phosphorylation. Digestion of nuclei with caspase-3-activated DFF
resulted in oligonucleosomal DNA ladders somewhat sharper than those
generated by MNase, as judged by oligonucleosomal multimer band
sharpness and the ability to visualize bands of longer oligomers. This
is because the interband background between successive oligonucleosomal
multimers was higher for MNase digestion products; unlike MNase, DDF
lacks exonuclease activity. Furthermore, cleavage within nucleosome
core particles was undetectable for DFF digestion products, in contrast
to MNase digestion products, which exhibited subnucleosomal DNA
fragments (Fig. 3A, compare lanes 6 and 7 with lanes 9 and 10;
Fig. 3C, compare lanes 1 and 3). We conclude that DFF is another reagent useful for
chromatin research.

View larger version (82K):
[in this window]
[in a new window]
|
Fig. 3.
Comparison of DNA cleavage patterns of MNase
and caspase-3-activated DFF on chromatin of HeLa cell nuclei.
A, HeLa cell nuclei were incubated as described under
"Experimental Procedures" in the presence or absence of the
indicated proteins for the specified times in a buffer
(Mg/Ca) containing 3 mM MgCl2 plus 3 mM CaCl2 for MNase digestion at 25 °C or
containing 3 mM MgCl2 for caspase-3-activated
DFF digestion at 33 °C. DNA was purified, resolved on an agarose
gel, and visualized after staining with ethidium bromide. M,
molecular weight markers. B, purified HeLa cell DNA was
cleaved at 37 °C with caspase-3-activated DFF for the indicated
times as described under "Experimental Procedures." DNA digestion
products were purified and resolved on an agarose gel, and DNA was
visualized after staining with ethidium bromide. M,
molecular weight markers. C, the DNA samples from
A (lanes 7 and 9) were
resolved on a 5% acrylamide gel and visualized after staining with
ethidium bromide. M, molecular weight markers.
|
|
In order to establish an in vitro system to study further
the action of DFF endonuclease on chromatin, we chose as a model substrate for in vitro chromatin assembly an 18-mer of a
207-bp 5 S rRNA gene sequence, which has been previously shown by
Simpson and co-workers (22) to position nucleosomes on each tandem
repeat. We then used a salt step gradient procedure with purified HeLa cell core histones to reconstitute nucleosomes onto this 5 S gene tandem array (see "Experimental Procedures"). As shown in Fig. 4, both DFF endonuclease and MNase
generated nucleosomal DNA ladders upon digestion of the reconstituted
chromatin. However, just as in the nuclear chromatin digests (Fig. 3),
it is significant that the nucleosomal DNA ladders generated by DFF
endonuclease are sharper than those generated by MNase. Therefore, DFF
may be better than MNase as a reagent for some types of chromatin
structural analyses. As expected, digestion of the naked DNA control
only generated a nondiscrete smear of DNA fragmentation products (Fig. 4). Interestingly, the kinetics of DNA fragmentation by DFF
endonuclease on naked DNA are only severalfold faster than on the
chromatin substrate (as judged by the intensities of the high molecular weight doublet bands) (see also Fig. 6), whereas we note that MNase or
DNase I attack naked DNA much more rapidly than chromatin (data not
shown). We interpret this result as follows. The assembly of DNA into
nucleosome core particles, which would be expected to reduce DNA
cleavage accessibility, is compensated by an activation of DFF
endonuclease by nucleosomal DNA wrapping (see below). In summary, we
can generate nucleosomal DNA ladders by digestion of isolated nuclei or
in vitro assembled chromatin with activated DFF very much
like those generated in vivo during the terminal stages of
apoptosis.

View larger version (91K):
[in this window]
[in a new window]
|
Fig. 4.
Cleavage of reconstituted chromatin by
caspase-3-activated DFF. An 18-mer of the 5 S rRNA gene, as naked
DNA or in vitro reconstituted chromatin, was incubated in
the presence of caspase-3 and DFF for 5, 10, 20, and 40 min at
37 °C. As a control, the reconstituted chromatin was also separately
incubated with MNase (0.1 units/µl, with 3 mM
CaCl2) for 1, 3, 10, and 30 min at 25 °C. DNA digestion
products were purified and resolved on an agarose gel, and DNA was
visualized after staining with ethidium bromide. M,
molecular weight markers.
|
|
Caspase-3-activated DFF Cleaves Chromatin in the Internucleosomal
Linkers Leaving 5'-Phosphate and 3'-Hydroxyl Groups--
To prove that
DFF cuts in the linker region between nucleosomes, we isolated
mononucleosomal-length DNA fragments generated after digestion of the
in vitro reconstituted chromatin with DFF endonuclease and
mapped the positions of DNA cleavage with respect to the 5 S rRNA gene
repeat. For this purpose, we cut the mononucleosomal DNA with
EcoRI, whose pair of closely spaced recognition sequences are known to be located in the internucleosomal linker region after
nucleosomal assembly (22). We found that the majority of the DNA
fragments were reduced in length by 20 bp (Fig.
5, compare lanes 1 and 3), proving that the cutting sites for DFF and
EcoRI are close together in the internucleosomal linker
region (Fig. 5, bottom diagram). Quantitation by
PhosphorImager analysis revealed that 80% of these DNA molecules were
between 200 and 150 bp in length. The 20% below 150 bp in length may
be in part accounted for by a background of nonpositioned and/or
partially assembled nucleosomes generated under the conditions of
chromatin reconstitution that we employed. In addition, we found that
the DNA ends generated by DFF endonuclease possessed 3'-hydroxyl
groups, because they could be extended by terminal deoxynucleotidyl
transferase (Fig. 5, compare lanes 3 and
5), and radioactive nucleotides could be incorporated by
either terminal deoxynucleotidyl transferase, T4 or T7 DNA polymerase
(data not shown). In addition, the 5'-ends of DFF-generated
mononucleosomal DNA could not be phosphorylated by T4 polynucleotide
kinase unless they were first dephosphorylated by treatment with
alkaline phosphatase (Fig. 5, compare lanes 2 and
3), indicating the initial presence of 5'-phosphate groups. Finally, an extension reaction with T4 DNA polymerase barely shifted the DNA lengths of the products (Fig. 5, compare lanes
3 and 4), indicating the nearly blunt-end nature
of the cleavage products. Controls with restriction fragments bearing
5'-overhangs proved that the polymerase reaction was functional (data
not shown).

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 5.
Analysis of DNA ends generated by
caspase-3-activated DFF. Gel-purified mononucleosomal DNA
generated by caspase-3-activated DFF digestion of reconstituted rDNA
gene chromatin was 32P-5'-end labeled with T4
polynucleotide kinase after its dephosphorylation with alkaline
phosphatase (the sample in lane 2 was not treated
with phosphatase). DNA was then treated with EcoRI
(lane 1), T4 DNA polymerase (lane
4), or terminal deoxynucleotidyl transferase
(lane 5). The bottom
diagram shows the positions of DFF cutting in a 5 S rDNA
repeat. Gray bar, positioned nucleosome;
black arrows, EcoRI cleavage sites;
gray arrowheads, DFF cleavage sites in linker
DNA. b, bases.
|
|
Differential Activation of DFF Cleavage by Chromosomal Proteins on
Naked DNA and Chromatin Substrates--
We have previously reported
that DFF endonuclease cleavage of naked DNA substrates can be activated
approximately 20-fold by either histone H1 or HMG-1/2 (7, 12, 13). We
have also noted that assembly of naked DNA into chromatin does not
dramatically inhibit DFF digestion kinetics as opposed to those of
MNase (Fig. 4, data not shown). Histone H1 and HMG-1/2 each prefer to
bind to supercoiled DNA and DNA crossovers (49-51); such stimulation may be in part due to trapping DNA substrates in a conformation more
favorably attacked by DFF, which may resemble more closely the DNA
wrapping around the histone octamer. To test this hypothesis, we
decided to determine whether topoisomerase II, another protein that
prefers to bind to supercoiled DNA and DNA crossovers (52), could also
stimulate DFF endonuclease cleavage on a naked DNA substrate.
Topoisomerase II has also been shown to mediate the initial stages of
apoptotic DNA cleavage into 50-100-kb fragments under conditions of
oxidative stress (53), making it an even more attractive candidate
protein for further study. As shown in Fig.
6A, topoisomerase II proved to
also be an activator of DFF endonuclease activity to a level roughly
equivalent to that of histone H1 or HMG-1 (compare lane
4 with lanes 1-3); including higher
levels of HMG-1 or topoisomerase II resulted in a 20-fold activation
for either protein equivalent to that seen for histone H1 (data not
shown). On the other hand, when core histones were added under
conditions that did not lead to nucleosome formation, only inhibition
of DFF activity was observed (data not shown).

View larger version (66K):
[in this window]
[in a new window]
|
Fig. 6.
Activation of DFF cleavage by chromosomal
proteins on naked DNA and chromatin substrates. A, 1 µg of 5 S rDNA 18-mer naked DNA or in vitro reconstituted
chromatin were incubated at 37 °C for 15 min with
caspase-3-activated DFF and bovine serum albumin (200 ng), HeLa cell
histone H1 (100 ng), human HMG-1 (200 ng) (gift of Michael Bustin), or
human topoisomerase II (Topo II; 1 unit; Topogen) as
indicated. DNA digestion products were purified and resolved on an
agarose gel, and DNA was visualized after staining with ethidium
bromide. B, 1 µg of 5 S rDNA 18-mer in vitro
reconstituted core histone-containing or core histone plus histone
H1-containing chromatin were incubated at 25 °C with 1 unit of MNase
for 1, 3, 10, and 30 min or at 37 °C with caspase-3 activated DFF
for 5, 10, 20, and 40 min, as indicated. DNA digestion products were
purified and resolved on an agarose gel, and DNA was visualized after
staining with ethidium bromide.
|
|
In order to determine whether DFF activity could also be stimulated by
the addition of histone H1, HMG-1, or topoisomerase II to a chromatin
substrate, we pair-wise compared the effects of adding the same amounts
of these proteins on the cleavage kinetics of naked DNA and
reconstituted chromatin (Fig. 6A). We estimate that the
histone H1 addition stimulated naked DNA cleavage 20-fold (Fig.
6A, compare lanes 1 and 2)
but inhibited cleavage of chromatin about 2-fold (Fig. 6A,
compare lanes 5 and 6). HMG-1
stimulated naked DNA cleavage about 10-fold (Fig. 6A,
compare lanes 1 and 3) but only about
2-fold when added to reconstituted chromatin (Fig. 6A,
compare lanes 5 and 7). Topoisomerase
II stimulated naked DNA cleavage about 5-fold (Fig. 6A,
compare lanes 1 and 4) but only about
2-fold when added to reconstituted chromatin (Fig. 6A,
compare lanes 5 and 8). Thus, the
wrapping of DNA around histone octamers may partially mimic the
activation effects of histone H1, HMG-1, and topoisomerase II on
altering the conformation of naked DNA, which would tend to reduce the
degree of activation by these proteins on the chromatin substrate.
Finally, because the simple addition of histone H1 to reconstituted
core histone-containing chromatin may not correctly assemble the
protein onto nucleosomes, we employed step gradient dialysis to
correctly bind the protein to generate histone H1-containing
reconstituted chromatin (see "Experimental Procedures"). As shown
in Fig. 6B, upon assembly of histone H1 into chromatin,
MNase processing of oligonucleosomal to mononucleosomal DNA fragments
was inhibited 5-10-fold (Fig. 6B, compare lanes
1-4 with lanes 5-8), whereas such
processing by DFF was only inhibited approximately 3-fold by histone H1
assembly (Fig. 6B, compare lanes 9-12
with lanes 13-16). Thus, although histone H1
condenses chromatin, this conformational alteration is less inhibitory
to cleavage mediated by DFF as compared with MNase, perhaps because
reduced cleavage accessibility is compensated by an activation of DFF
endonuclease by further nucleosomal DNA wrapping.
 |
DISCUSSION |
It should be appreciated that the in vitro properties
of DFF endonuclease cleavage fit the phenotype of the DNA products
generated by apoptosis in vivo, namely nucleosomal DNA
ladders, with fragments bearing 3'-hydroxyl groups; these features have
been routinely used in bioassays for cells undergoing apoptosis. It is
interesting that DFF endonuclease cleavage of a naked DNA substrate is
markedly stimulated by topoisomerase II, a protein recently shown to be responsible for the creation of 50-100-kb DNA cleavage products during
the initial stages of oxidative stress-induced apoptosis (53). This
suggests a coordination or linkage between topoisomerase II and DFF in
triggering efficient DNA breakdown during the terminal stages of
apoptosis. Interestingly, the kinetics of DNA fragmentation by DFF
endonuclease on naked DNA and chromatin substrates are nearly
equivalent, in marked contrast to those of MNase or DNase I, which
attack naked DNA orders of magnitude more rapidly than chromatin.
Cleavage of naked DNA by DFF is activated by histone H1, HMG-1/2, and
topoisomerase II, proteins that trap supercoils and DNA crossovers,
which induce DNA conformations that partially mimic nucleosomal DNA
wrapping. DFF activation for chromatin cleavage by these proteins,
however, is much less than for naked DNA digestion. Thus, the assembly
of DNA into nucleosome core particles, which would be expected to
reduce DNA cleavage accessibility, is apparently compensated by an
activation of DFF endonuclease by the resulting nucleosomal DNA
wrapping. The observed activation of DFF endonuclease for naked DNA
cleavage may also in part be due to direct interactions with these
chromosomal proteins, which may recruit the enzyme to the DNA
substrates (12).
DFF has a place as a reagent for chromatin research. In the current
study, we have proven that the endonuclease cuts in the internucleosomal linker regions of chromatin. Although the possibility was remote, it was formally possible that the presumptive nucleosomal DNA ladders observed upon apoptotic cell death by researchers in the
field could have been a reflection of cleavage of chromatin at, for
example, the dyad axis of symmetry of the nucleosomal repeat. The
addition of caspase-3 alone or DFF alone to isolated nuclei did not
result in detectable DNA breakdown (Fig. 3, lanes 14 and 15). Although DFF exists in the nucleus of
living cells (7, 11), upon cellular fractionation during nuclei
isolation, the protein is found in the cytoplasmic fraction (6). This nuclear leakage of DFF upon cell fractionation means that
internucleosomal DNA laddering in isolated nuclei is dependent on the
addition of exogenous caspase-3-activated DFF (6). This feature is
ideal for experimentally controlling the extent of endonuclease
digestion. The DNA sequence preferences for DFF are more selective than
even MNase, however, indicating that the apoptotic endonuclease may not
be the reagent of choice for precise mapping of in vivo
nucleosome positions by first hit kinetics footprinting procedures.
However, the lack of exonuclease activity, the marked preference for
cleavage in the internucleosomal linker region, and the lack of
intranucleosomal DNA cleavage after production of mononucleosomes make
DFF an attractive choice for the generation and analysis of
mononucleosomes. The extent of DFF endonuclease recognition of
"nucleosome-free" regions known as DNase I-hypersensitive sites in
chromatin, the nature of putative DFF-resistant chromatin structures,
and how DFF attacks nucleosomal arrays in transcriptionally repressed
and active genes are interesting questions that remain to be addressed
in the future.
 |
ACKNOWLEDGEMENTS |
We thank Katherine Meyers for review of the
manuscript and Drs. Robert Simpson for permission to use the 5 S rRNA
gene-bearing plasmid, Shuyu Li for help with the graphics, and Michael
Bustin for the gift of HMG-1.
 |
FOOTNOTES |
*
This work was supported in part by the Polish State
Committee for Scientific Research Grant 6P04A01317 (to P. W.),
American Cancer Society Grant RE258, National Institutes of Health
Grant GMRO1-55942, Robert A. Welch Foundation Grant I-1412 (to
X. W.), National Institutes of Health Grant GMRO1-29935, and Robert A. Welch Foundation Grant I-0823 (to W. T. G.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Present address: Dept. of Experimental and Clinical Radiobiology,
Center of Oncology, 44-100 Gliwice, Poland.
¶
Present address: Inst. of Molecular and Cell Biology, 30 Medical Dr., Singapore 117609.

To whom correspondence and reprint requests should be
addressed: Dept. of Molecular Biology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75235-9148. Tel.:
214-648-1924; Fax: 214-648-1909; E-mail: garrard@utsw.swmed.edu.
2
M. Xu, personal communication.
 |
ABBREVIATIONS |
The abbreviations used are:
DFF, DNA
fragmentation factor;
CAD, caspase-activated deoxyribonuclease (also
termed DFF40);
CPAN, caspase-activated nuclease (also termed DFF40 and CAD);
DFF45, 45-kDa subunit of DFF;
DFF40, 40-kDa subunit of DFF;
HMG, high mobility group;
ICAD, inhibitor of CAD (also termed DFF45);
MNase, micrococcal nuclease;
LTR, long terminal repeat;
bp, base pair(s);
kb, kilobase pair(s).
 |
REFERENCES |
| 1.
|
Jacobson, M. D.,
Weil, M.,
and Raff, M. C.
(1997)
Cell
88,
347-354[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Nagata, S.
(1997)
Cell
88,
355-365[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Wyllie, A. H.
(1980)
Nature
284,
555-556[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Wyllie, A. H.,
Morris, R. G.,
Smith, A. L.,
and Dunlop, D.
(1984)
J. Pathol.
142,
66-77
|
| 5.
|
Compton, M. M.
(1992)
Cancer Metast. Rev.
11,
105-119[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Liu, X.,
Zou, H.,
Slaughter, C.,
and Wang, X.
(1997)
Cell
89,
175-184[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Liu, X.,
Li, P.,
Widlak, P.,
Zou, H.,
Luo, X.,
Garrard, W. T.,
and Wang, X.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
8461-8466[Abstract/Free Full Text]
|
| 8.
|
Enari, M.,
Sakahira, H.,
Yokoyama, H.,
Okawa, K.,
Iwamatsu, A.,
and Nagata, S.
(1998)
Nature
391,
43-50[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Sakahira, H.,
Enari, M.,
and Nagata, S.
(1998)
Nature
391,
96-99[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Halenbeck, R.,
MacDonald, H.,
Roulston, A.,
Chen, T. T.,
Conroy, L.,
and Williams, L. T.
(1998)
Curr. Biol.
8,
537-540[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Samejima, K.,
and Earnshaw, W. C.
(1998)
Exp. Cell Res.
243,
453-459[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Liu, X.,
Zou, H.,
Widlak, P.,
Garrard, W.,
and Wang, X.
(1999)
J. Biol. Chem.
274,
13836-13840[Abstract/Free Full Text]
|
| 13.
|
Toh, S. Y.,
Wang, X.,
and Li, P.
(1998)
Biochem. Biophys. Res. Commun.
250,
598-601[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Zhang, J.,
Liu, X.,
Scherer, D. C.,
Kaer, L. V.,
Wang, X.,
and Xu, M.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
12,480-12,485[Abstract/Free Full Text]
|
| 15.
| Zhang, J., Wang, X., Bove, K. E., and Xu, M. (1999) J. Biol. Chem.(In Press)
|
| 16.
|
Inohara, N.,
Koseki, T.,
Chen, S.,
Wu, X.,
and Nunez, G.
(1998)
EMBO J.
17,
2526-2533[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Sakahira, H.,
Enari, M.,
and Nagata, S.
(1999)
J. Biol. Chem.
274,
15,740-15,744[Abstract/Free Full Text]
|
| 18.
|
Gu, J.,
Dong, R.-P.,
Zhang, C.,
McLaughlin, D. F.,
Wu, M. X.,
and Schlossman, S. F.
(1999)
J. Biol. Chem.
274,
20,759-20,762[Abstract/Free Full Text]
|
| 19.
|
Susin, S. A.,
Lorenzo, H. K.,
Zamzami, N.,
Marzo, I.,
Snow, B. E.,
Brothers, G. M.,
Mangion, J.,
Jacotot, E.,
Costantini, P.,
Loeffler, M.,
Larochette, N.,
Goodlett, D. R.,
Aebersold, R.,
Siderovski, D. P.,
Penninger, J. M.,
and Kroemer, G.
(1999)
Nature
397,
441-446[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Sakahira, H.,
Enari, M.,
Ossawa, Y.,
Uchiyama, Y.,
and Nagata, S.
(1999)
Curr. Biol.
9,
543-546[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
van Holde, K. E.
(1988)
Chromatin
, Springer, Berlin
|
| 22.
|
Simpson, R. T.,
Thoma, F.,
and Brubaker, J. M.
(1985)
Cell
42,
799-808[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Rhodes, D.,
and Laskey, R. A.
(1989)
Methods Enzymol.
170,
575-585[Medline]
[Order article via Infotrieve]
|
| 24.
|
Stein, A.
(1989)
Methods Enzymol.
170,
585-603[Medline]
[Order article via Infotrieve]
|
| 25.
|
Simon, R.,
and Felsenfeld, G.
(1979)
Nucleic Acids Res.
6,
689-696[Abstract/Free Full Text]
|
| 26.
|
Widlak, P.,
Gaynor, R. B.,
and Garrard, W. T.
(1997)
J. Biol. Chem.
272,
17654-17661[Abstract/Free Full Text]
|
| 27.
|
Fernandes, R. S.,
and Cotter, T. G.
(1993)
Anticancer Res.
13,
1253-1259[Medline]
[Order article via Infotrieve]
|
| 28.
|
Torriglia, A.,
Perani, P.,
Brossas, J. Y.,
Chaudun, E.,
Treton, J.,
Courtois, Y.,
and Counis, M.-F.
(1998)
Mol. Cell. Biol.
18,
3612-3619[Abstract/Free Full Text]
|
| 29.
|
Krieser, R. J.,
and Eastman, A.
(1998)
J. Biol. Chem.
273,
30909-30914[Abstract/Free Full Text]
|
| 30.
|
Gaido, M. L.,
and Cidlowski, J. A.
(1991)
J. Biol. Chem.
266,
18580-18585[Abstract/Free Full Text]
|
| 31.
|
Seiliev, A. A.,
Zvonareva, N. B.,
Zhivotovsky, B. D.,
and Hanson, K. P.
(1992)
Radiat. Environ. Biophys.
31,
123-132[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Peitsch, M. C.,
Polzar, B.,
Stephan, H.,
Crompton, T.,
MacDonald, H. R.,
Mannherz, H. G.,
and Tschopp, J.
(1993)
EMBO J.
12,
371-377[Medline]
[Order article via Infotrieve]
|
| 33.
|
Shiokawa, D.,
Ohyama, H.,
Yamada, T.,
Takahashi, K.,
and Tanuma, S.
(1994)
Eur. J. Biochem.
226,
23-30[Medline]
[Order article via Infotrieve]
|
| 34.
|
Pandey, S.,
Walker, P. R.,
and Sikorska, M.
(1997)
Biochemistry
36,
711-720[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Hughes, F. M., Jr.,
Evans-Storms, R. B.,
and Cidlowski, J. A.
(1998)
Cell Death Differ.
5,
1017-1027[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Urbano, A.,
McCaffrey, R.,
and Foss, F.
(1998)
J. Biol. Chem.
273,
34820-34827[Abstract/Free Full Text]
|
| 37.
|
Yakovlev, A. G.,
Wang, G.,
Stoica, B. A.,
Simbulan-Rosenthal, C. M.,
Yoshihara, K.,
and Smulson, M. E.
(1999)
Nucleic Acids Res.
27,
1999-2005[Abstract/Free Full Text]
|
| 38.
|
Kawabata, H.,
Anzai, N.,
Masutani, H.,
Hirama, T.,
Yoshida, Y.,
and Okuma, M.
(1993)
Biochem. Biophys. Res. Commun.
191,
247-254[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Yoshida, A.,
Pourquier, P.,
and Pommier, Y.
(1998)
Cancer Res.
58,
2576-2582[Abstract/Free Full Text]
|
| 40.
|
Zhang, C.,
Robertson, M. J.,
and Schlossman, S. F.
(1995)
Cell Immunol.
165,
161-167[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
Montague, J. W.,
Hughes Jr, F. M.,
and Cidlowski, J. A.
(1997)
J. Biol. Chem.
272,
6677-6884[Abstract/Free Full Text]
|
| 42.
|
Price, P. A.
(1975)
J. Biol. Chem.
250,
1981-1986[Abstract/Free Full Text]
|
| 43.
|
Ojcius, D. M.,
Zychlinsky, A.,
Zheng, L. M.,
and Young, J. D. -E.
(1991)
Exp. Cell. Res.
197,
43-49[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Sun, D. Y.,
Jiang, S.,
Zheng, L. -M.,
Ojcius, D. M.,
and Young, J. D. -E.
(1994)
J. Exp. Med.
179,
559-568[Abstract/Free Full Text]
|
| 45.
|
Hörz, W.,
and Altenburger, W.
(1981)
Nucleic Acids Res.
9,
2643-2658[Abstract/Free Full Text]
|
| 46.
|
Dingwall, C.,
Lomonossoff, G. P.,
and Laskey, R. A.
(1981)
Nucleic Acids Res.
9,
2659-2673[Abstract/Free Full Text]
|
| 47.
|
Drew, H. R.,
and Travers, A. A.
(1984)
Cell
37,
491-502[CrossRef][Medline]
[Order article via Infotrieve]
|
| 48.
|
Drew, H. R.
(1984)
J. Mol. Biol.
176,
535-557[CrossRef][Medline]
[Order article via Infotrieve]
|
| 49.
|
Ivanchenko, M.,
Zlatanova, J.,
and van Holde, K.
(1997)
Biophys J.
72,
1388-1395[Medline]
[Order article via Infotrieve]
|
| 50.
|
Krylov, D.,
Leuba, S.,
van Holde, K.,
and Zlatanova, J.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
5052-5056[Abstract/Free Full Text]
|
| 51.
|
Bianchi, M. E.,
Beltrame, M.,
and Paonessa, G.
(1989)
Science
243,
1056-1059[Abstract/Free Full Text]
|
| 52.
|
Wang, J. C.
(1996)
Ann. Rev. Biochem.
65,
635-692[CrossRef][Medline]
[Order article via Infotrieve]
|
| 53.
|
Li, T.-K.,
Chen, A. Y., Yu, C.,
Mao, Y.,
Wang, H.,
and Liu, L. F.
(1999)
Genes Dev.
13,
1553-1560[Abstract/Free Full Text]
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
F. Xiao, P. Widlak, and W. T. Garrard
Engineered apoptotic nucleases for chromatin research
Nucleic Acids Res.,
July 26, 2007;
35(13):
e93 - e93.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-T. Wang, W.-J. Yang, C.-L. Li, L. G. Doudeva, and H. S. Yuan
Structural basis for sequence-dependent DNA cleavage by nonspecific endonucleases
Nucleic Acids Res.,
January 28, 2007;
35(2):
584 - 594.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Johnson, F. J. Tan, H. L. McCullough, D. P. Riordan, and A. Z. Fire
Flexibility and constraint in the nucleosome core landscape of Caenorhabditis elegans chromatin
Genome Res.,
December 1, 2006;
16(12):
1505 - 1516.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Otake, A. Mims, and D. J. Fernandes
Merbarone Induces Activation of Caspase-Activated DNase and Excision of Chromosomal DNA Loops from the Nuclear Matrix
Mol. Pharmacol.,
April 1, 2006;
69(4):
1477 - 1485.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kyoi, H. Otani, S. Matsuhisa, Y. Akita, K. Tatsumi, C. Enoki, H. Fujiwara, H. Imamura, H. Kamihata, and T. Iwasaka
Opposing effect of p38 MAP kinase and JNK inhibitors on the development of heart failure in the cardiomyopathic hamster
Cardiovasc Res,
March 1, 2006;
69(4):
888 - 898.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Reh, C. Korn, O. Gimadutdinow, and G. Meiss
Structural Basis for Stable DNA Complex Formation by the Caspase-activated DNase
J. Biol. Chem.,
December 16, 2005;
280(50):
41707 - 41715.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Lechardeur, S. Dougaparsad, C. Nemes, and G. L. Lukacs
Oligomerization State of the DNA Fragmentation Factor in Normal and Apoptotic Cells
J. Biol. Chem.,
December 2, 2005;
280(48):
40216 - 40225.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Liu, A. Vo, G. Liu, and W. L. McKeehan
Distinct Structural Domains within C19ORF5 Support Association with Stabilized Microtubules and Mitochondrial Aggregation and Genome Destruction
Cancer Res.,
May 15, 2005;
65(10):
4191 - 4201.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. West, C. Ji, and L. J. Marnett
Modulation of DNA Fragmentation Factor 40 Nuclease Activity by Poly(ADP-ribose) Polymerase-1
J. Biol. Chem.,
April 15, 2005;
280(15):
15141 - 15147.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Korn, S. R. Scholz, O. Gimadutdinow, R. Lurz, A. Pingoud, and G. Meiss
Interaction of DNA Fragmentation Factor (DFF) with DNA Reveals an Unprecedented Mechanism for Nuclease Inhibition and Suggests That DFF Can Be Activated in a DNA-bound State
J. Biol. Chem.,
February 18, 2005;
280(7):
6005 - 6015.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Widlak, J. Lanuszewska, R. B. Cary, and W. T. Garrard
Subunit Structures and Stoichiometries of Human DNA Fragmentation Factor Proteins before and after Induction of Apoptosis
J. Biol. Chem.,
July 11, 2003;
278(29):
26915 - 26922.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. V. Didenko, H. Ngo, and D. S. Baskin
Early Necrotic DNA Degradation: Presence of Blunt-Ended DNA Breaks, 3' and 5' Overhangs in Apoptosis, but only 5' Overhangs in Early Necrosis
Am. J. Pathol.,
May 1, 2003;
162(5):
1571 - 1578.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Ben-Yehudah, R. Aqeilan, D. Robashkevich, and H. Lorberboum-Galski
Using Apoptosis for Targeted Cancer Therapy by a New Gonadotropin Releasing Hormone-DNA Fragmentation Factor 40 Chimeric Protein
Clin. Cancer Res.,
March 1, 2003;
9(3):
1179 - 1190.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Mukae, H. Yokoyama, T. Yokokura, Y. Sakoyama, and S. Nagata
Activation of the innate immunity in Drosophila by endogenous chromosomal DNA that escaped apoptotic degradation
Genes & Dev.,
October 15, 2002;
16(20):
2662 - 2671.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. T. Solovyan, Z. A. Bezvenyuk, A. Salminen, C. A. Austin, and M. J. Courtney
The Role of Topoisomerase II in the Excision of DNA Loop Domains during Apoptosis
J. Biol. Chem.,
June 7, 2002;
277(24):
21458 - 21467.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Widlak, O. Palyvoda, S. Kumala, and W. T. Garrard
Modeling Apoptotic Chromatin Condensation in Normal Cell Nuclei. REQUIREMENT FOR INTRANUCLEAR MOBILITY AND ACTIN INVOLVEMENT
J. Biol. Chem.,
June 7, 2002;
277(24):
21683 - 21690.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Widlak, L. Y. Li, X. Wang, and W. T. Garrard
Action of Recombinant Human Apoptotic Endonuclease G on Naked DNA and Chromatin Substrates. COOPERATION WITH EXONUCLEASE AND DNase I
J. Biol. Chem.,
December 14, 2001;
276(51):
48404 - 48409.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. S. Taper, J. M. Jamison, J. Gilloteaux, C. A. Gwin, T. Gordon, and J. L. Summers
In Vivo Reactivation of DNases in Implanted Human Prostate Tumors After Administration of a Vitamin C/K3 Combination
J. Histochem. Cytochem.,
January 1, 2001;
49(1):
109 - 120.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Frustaci, J. Kajstura, C. Chimenti, I. Jakoniuk, A. Leri, A. Maseri, B. Nadal-Ginard, and P. Anversa
Myocardial Cell Death in Human Diabetes
Circ. Res.,
December 8, 2000;
87(12):
1123 - 1132.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kratzmeier, W. Albig, K. Hanecke, and D. Doenecke
Rapid Dephosphorylation of H1 Histones after Apoptosis Induction
J. Biol. Chem.,
September 22, 2000;
275(39):
30478 - 30486.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. H. Boulares, A. J. Zoltoski, A. Yakovlev, M. Xu, and M. E. Smulson
Roles of DNA Fragmentation Factor and Poly(ADP-ribose) Polymerase in an Amplification Phase of Tumor Necrosis Factor-induced Apoptosis
J. Biol. Chem.,
October 5, 2001;
276(41):
38185 - 38192.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|